Mitoxantrone and GM-CSF: a phase I study with an escalated dose of mitoxantrone in breast cancer.
ten Bokkel Huinink
W W
WW
The Netherlands Cancer Institute, Amsterdam.
Clavel
M
M
Rodenhuis
S
S
Guastalla
J P
JP
Franklin
H R
HR
Koier
J J
JJ
Vlasveld
T
T
Dalesio
O
O
van Tinteren
H
H
Pinedo
H M
HM
D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control*; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D008942:Mitoxantrone